Literature DB >> 11097517

Minimum standards for electromyography in Canada: a statement of the Canadian Society of Clinical Neurophysiologists.

C F Bolton1, T J Benstead, F Grand'Maison, G S Tardif, L E Weston.   

Abstract

BACKGROUND: Electromyography (EMG) is a widely used diagnostic technique for disorders of the nervous system. The Canadian Society of Clinical Neurophysiologists (CSCN) promotes the education, evaluation and standards of EMG in Canada. A statement of practice standards was needed to clarify the position of the CSCN on several issues relevant to the practice of EMG. METHODS AND
RESULTS: A subcommittee of the CSCN reviewed current patterns of practice and established guidelines for review by the CSCN. The guidelines developed by the subcommittee were reviewed by the CSCN and adopted as recommendations for EMG practice. The subcommittee was charged with formulation of a document for publication.
CONCLUSIONS: This document deals with minimum standards for electromyographer education, laboratory operation, equipment and a variety of special circumstances relevant to the practice of EMG. The standards can be adopted by EMG laboratories to guide quality assurance.

Mesh:

Year:  2000        PMID: 11097517     DOI: 10.1017/s0317167100001013

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  12 in total

1.  Conduction slowing in diabetic sensorimotor polyneuropathy.

Authors:  Samantha K Dunnigan; Hamid Ebadi; Ari Breiner; Hans D Katzberg; Leif E Lovblom; Bruce A Perkins; Vera Bril
Journal:  Diabetes Care       Date:  2013-09-11       Impact factor: 19.112

2.  Treatment Responsiveness in CIDP Patients with Diabetes Is Associated with Higher Degrees of Demyelination.

Authors:  Alon Abraham; Majed Alabdali; Mohammad Qrimli; Hana Albulaihe; Ari Breiner; Carolina Barnett; Hans D Katzberg; Leif E Lovblom; Bruce A Perkins; Vera Bril
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

3.  Laser Doppler Flare Imaging and Quantitative Thermal Thresholds Testing Performance in Small and Mixed Fiber Neuropathies.

Authors:  Alon Abraham; Majed Alabdali; Abdulla Alsulaiman; Ari Breiner; Carolina Barnett; Hans D Katzberg; Leif E Lovblom; Bruce A Perkins; Vera Bril
Journal:  PLoS One       Date:  2016-11-08       Impact factor: 3.240

4.  Identification and prediction of diabetic sensorimotor polyneuropathy using individual and simple combinations of nerve conduction study parameters.

Authors:  Alanna Weisman; Vera Bril; Mylan Ngo; Leif E Lovblom; Elise M Halpern; Andrej Orszag; Bruce A Perkins
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

5.  Can ultrasound of the tibial nerve detect diabetic peripheral neuropathy? A cross-sectional study.

Authors:  Sheila Riazi; Vera Bril; Bruce A Perkins; Sherif Abbas; Vincent W S Chan; Mylan Ngo; Leif E Lovblom; Hossam El-Beheiry; Richard Brull
Journal:  Diabetes Care       Date:  2012-10-01       Impact factor: 19.112

6.  Standardization of surface electromyography utilized to evaluate patients with dysphagia.

Authors:  Michael Vaiman
Journal:  Head Face Med       Date:  2007-06-06       Impact factor: 2.151

Review 7.  Surface electromyography as a screening method for evaluation of dysphagia and odynophagia.

Authors:  Michael Vaiman; Ephraim Eviatar
Journal:  Head Face Med       Date:  2009-02-20       Impact factor: 2.151

8.  The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with and without diabetes--an observational study.

Authors:  Samantha K Dunnigan; Hamid Ebadi; Ari Breiner; Hans D Katzberg; Carolina Barnett; Bruce A Perkins; Vera Bril
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

9.  Comparison of monoclonal gammopathy of undetermined significance-associated neuropathy and chronic inflammatory demyelinating polyneuropathy patients.

Authors:  Nuha M Alkhawajah; Samantha K Dunnigan; Vera Bril
Journal:  J Neurol       Date:  2014-05-07       Impact factor: 4.849

10.  Elevated Vibration Perception Thresholds in CIDP Patients Indicate More Severe Neuropathy and Lower Treatment Response Rates.

Authors:  Alon Abraham; Hana Albulaihe; Majed Alabdali; Mohammad Qrimli; Ari Breiner; Carolina Barnett; Hans D Katzberg; Leif E Lovblom; Bruce A Perkins; Vera Bril
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.